Longport, Inc. (LPTI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: May 22, 2025
Longport Company Description
Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States.
It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue.
The company’s products are used in wound assessment, wound prevention, clinical dermatology, and aesthetics/plastics, as well as in various other applications, including burn assessment, superficial musculoskeletal imaging, and veterinary applications.
It also exports its products. The company was founded in 1993 and is based in Chadds Ford, Pennsylvania.
Longport, Inc.
| Country | United States |
| Founded | 1993 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Michael Boyd |
Contact Details
Address: 1620 Baltimore Pike Chadds Ford, Delaware 19317 United States | |
| Phone | 610-361-9100 |
| Website | longportinc.com |
Stock Details
| Ticker Symbol | LPTI |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US5431371039 |
| SIC Code | 3861 |
Key Executives
| Name | Position |
|---|---|
| Michael C. Boyd | Chairman and Chief Executive Officer |
| Paul D. Wilson | President, Chief Financial Officer, Director and MD of Longport International - UK |
| John P. Calabrese | Director of Sales and Marketing |